Aspirin in Reduction of Tension II Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.
Also called NCT01379079
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 290 participants
- Registry
-
NCT01379079 -
2010-024448-13
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01379079. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin in Reduction of Tension II Study
- Acronym
- ASPIRETENSION
- Condition
- Hypertension
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Acetylsalicylic acid
- Intervention (Drug)
- Acetylsalicylic acid lysinate
- Lead sponsor
- Leiden University Medical Center
- Collaborator
- Netherlands Heart Foundation
Record details
- Record id
cardio:ct-nct01379079- Content hash
f273a7fafa177ecc204a3cd2d5e8fdb28925306985c0f0ccc4a5eea565feda0e